Nordic survey examines multidisciplinary team meetings for lung cancer, revealing key operational insights.
A senior respiratory physician functioning as a leader of lung cancer MDT meetings from each of the four participating countries, were invited to participate in the development of the survey questions and to distribute the survey nationally.All lung cancer MDT meetings in Denmark (n = 7), regional MDT meetings in Norway (n = 7), and treating hospitals in Finland (n = 20) and Sweden (n = 21) were invited to participate.In Norway, only regional MDT meetings were included to ensure comparable case complexity and access to thoracic surgery.One reminder was sent after 2 weeks. Survey instrumentThe questionnaire comprised 53 items addressing:-MDT composition and leadership -Governance and guideline support -Meeting frequency and duration -Case volume and patient selection -Infrastructure and remote participation -Biomarker testing -Perceived barriers and drivers
No takes yet. Share an insight, caveat, or question.
Gouliaev et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: